Abstract
Investigators publish new report on artificial intelligence. According to news originating from Mountain View, California, by NewsRx correspondents, research stated, “Dogs with B-cell lymphoma typically respond well to first-line CHOP-based chemotherapy, but there is no standard of care for relapsed patients.” The news editors obtained a quote from the research from ImpriMed Inc.: “To help veterinary oncologists select effective drugs for dogs with lymphoid malignancies such as B-cell lymphoma, we have developed multimodal machine learning models that integrate data from multiple tumor profiling modalities and predict the likelihood of a positive clinical response for 10 commonly used chemotherapy drugs. Here we report on clinical outcomes that occurred after oncologists received a prediction report generated by our models.”
NETL
NSTL
Frontiers Media Sa